Search

Search form

Robert Peabody Comments on the Aegerion Pharmaceuticals Drug Marketing Case

Robert Peabody Comments on the Aegerion Pharmaceuticals Drug Marketing Case

Robert Peabody comments on the recent sentence of Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug in "Cambridge pharmaceutical company ordered to pay $7.2 million in restitution," published by the Boston Globe.

Subscription may be required to view article

 

People

Robert L. Peabody

Robert L. Peabody

Email